pharma bio & chem

Pharma & Biotech Global Week in Review 21 March 2012 from IP Think Tank

March 21, 2012 05:32

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Nexavar (Sorafenib) – India: Controversial licence granted over patented cancer drug (IP Whiteboard) (IPKat) (Patent...

Pharma & Biotech Global Week in Review 14 March 2012 from IP Think Tank

March 14, 2012 06:13

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Nexavar (Sorafenib) – India’s first compulsory license granted!: Bayer v Natco (Spicy IP) (Apothecurry) (IP...

Pharma & Biotech Global Week in Review 7 March 2012 from IP Think Tank

March 07, 2012 10:33

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Co-Diovan (Valsartan, Hydrochlorothiazide) – EU: CJEU sprints to reasoned order in Case C-422/11 Novartis v...

Pharma & Biotech Global Week in Review 19 Oct 2011 from IP Think Tank

October 19, 2011 10:30

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: EU: No more patents for cells derived from human embryos in EU – ECJ issues final verdict in Brüstle v Greenpeace...

Pharma & Biotech Global Week in Review 12 Oct 2011 from IP Think Tank

October 12, 2011 10:46

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Indian generics Aurobindo Pharma Limited and MedChem join Medicines Patent Pool (Spicy IP) (IP Watch) (IPBiz)  ...